Leveljump Healthcare Corp. announced a non-brokered private placement financing of up to 10,000,000 units at CAD 1 per unit for gross proceeds of up to CAD 10,000,000 on October 25, 2022. Each unit will consist of one common share, at an issue price of CAD 0.10 per common share; and one 8% cumulative redeemable convertible Class A Series 1 preferred share, at an issue price of CAD 0.90 per preferred share.

Each preferred share is non-voting, carries a cumulative annual dividend of 8% payable quarterly, are redeemable on the fifth anniversary after issuance at a price of CAD 1 per preferred share together with all accrued and unpaid dividends, or at a price of CAD 1.10 per preferred share. The offering is expected to close in November 2022. The offering is conditional upon receipt of all required regulatory approvals, including the approval of the TSX Venture Exchange.

The securities to be issued under the offering will have a hold period of four months and one day from the closing date of the offering in accordance with applicable securities laws.